Skip to main content
Top
Published in: Obesity Surgery 10/2010

01-10-2010 | Letter to the Editor

The Relationship of Plasma Adiponectin with Liver Fibrosis in Morbid Obesity

Authors: Teoman Dogru, Nuri Karadurmus, Guldem Kilciler, Serkan Tapan, Cemal Nuri Ercin

Published in: Obesity Surgery | Issue 10/2010

Login to get access

Excerpt

To the Editor: …
Literature
1.
2.
go back to reference Huang HL, Lin WY, Lee LT, et al. Metabolic syndrome is related to nonalcoholic steatohepatitis in severely obese subjects. Obes Surg. 2007;17:1457–63.CrossRefPubMed Huang HL, Lin WY, Lee LT, et al. Metabolic syndrome is related to nonalcoholic steatohepatitis in severely obese subjects. Obes Surg. 2007;17:1457–63.CrossRefPubMed
3.
go back to reference Gulcelik NE, Usman A, Gurlek A. Role of adipocytokines in predicting the development of diabetes and its late complications. Endocrine. 2009; Sep 25. doi:10.1007/s12020-009-9234-7. Gulcelik NE, Usman A, Gurlek A. Role of adipocytokines in predicting the development of diabetes and its late complications. Endocrine. 2009; Sep 25. doi:10.​1007/​s12020-009-9234-7.
4.
go back to reference Otsuka F, Sugiyama S, Kojima S, et al. Hypoadiponectinemia is associated with impaired glucose tolerance and coronary artery disease in non-diabetic men. Circ J. 2007;71:1703–9.CrossRefPubMed Otsuka F, Sugiyama S, Kojima S, et al. Hypoadiponectinemia is associated with impaired glucose tolerance and coronary artery disease in non-diabetic men. Circ J. 2007;71:1703–9.CrossRefPubMed
5.
go back to reference Yun JW, Cho YK, Park JH, et al. Abnormal glucose tolerance in young male patients with nonalcoholic fatty liver disease. Liver Int. 2009;29(4):525–9.CrossRefPubMed Yun JW, Cho YK, Park JH, et al. Abnormal glucose tolerance in young male patients with nonalcoholic fatty liver disease. Liver Int. 2009;29(4):525–9.CrossRefPubMed
6.
go back to reference Yilmaz MI, Sonmez A, Caglar K, et al. Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome. Nephrology (Carlton). 2007;12:147–53.CrossRef Yilmaz MI, Sonmez A, Caglar K, et al. Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome. Nephrology (Carlton). 2007;12:147–53.CrossRef
7.
go back to reference Lee JM, Kim JH, Son H, et al. Valsartan increases circulating adiponectin levels without changing HOMA-IR in patients with type 2 diabetes mellitus and hypertension. J Int Med Res. 2010;38:234–41.PubMed Lee JM, Kim JH, Son H, et al. Valsartan increases circulating adiponectin levels without changing HOMA-IR in patients with type 2 diabetes mellitus and hypertension. J Int Med Res. 2010;38:234–41.PubMed
Metadata
Title
The Relationship of Plasma Adiponectin with Liver Fibrosis in Morbid Obesity
Authors
Teoman Dogru
Nuri Karadurmus
Guldem Kilciler
Serkan Tapan
Cemal Nuri Ercin
Publication date
01-10-2010
Publisher
Springer-Verlag
Published in
Obesity Surgery / Issue 10/2010
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-010-0195-y

Other articles of this Issue 10/2010

Obesity Surgery 10/2010 Go to the issue